Hydrogen peroxide inhibits activity of the IGF-1 receptor kinase

Redox Report

Volumn 11, Issue 3, 2006, Pages 105-109

  Schmitt, Thomas L ^a   Klein, Helmut ^b   Dröge, Wulf ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

IGF 1 receptor; Insulin receptor; Oxidative stress; Signal transduction; Tyrosine kinases

Indexed keywords

GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; INSULIN; INSULIN RECEPTOR KINASE; RECOMBINANT ENZYME; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; CELL PROLIFERATION; GLUTATHIONE TRANSFERASE; HUMANS; HYDROGEN PEROXIDE; KINETICS; LIPID METABOLISM; OXIDATIVE STRESS; PHOSPHATES; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 33746329619     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100006X116574     Document Type: Article

References (18)

1. Nakae J, Kido Y. Accilli D. Distinct and overlapping functions of insulin and IGF-1 receptors. Endocrine Rev 2001; 22: 818-835
2. Kadowaki T, Tobe K, Honda-Yamamoto R et al. Signal transduction mechanism of insulin and insulin-like growth factor 1. Endocr J 1996; 43 (Suppl): S33-S41.
3. Baserga R, Peruzzi F, Reiss, K. The IGF-1 receptor in cancer biology. Int J Cancer 2003; 107: 873-877.
4. Favelyukis S, Till JH, Hubbard SR, Miller WT. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol 2001; 8: 1058-1063.
5. Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 1997; 16: 5572-5581.
6. Pautsch A, Zoephel A, Ahorn H, Spevak W, Hauptmann R, Nar H. Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure 2001; 9: 955-965.
7. 2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem 1997; 272: 10135-10143.
8. Koshio O, Akanuma Y, Kasuga M. Hydrogen peroxide stimulates tyrosine phosphorylation of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem J 1988; 250: 95-101.
9. Schmid E, El Benna J, Galter D, Klein G, Dröge W. Redox priming of the insulin receptor β-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 1998; 12: 863-870.
10. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 2001; 276: 21938-21942.
11. Schmitt TL, Hotz-Wagenblatt A, Klein H, Dröge W. Interdependent regulation of insulin receptor kinase activity by ADP and hydrogen peroxide. J Biol Chem 2005; 280: 3795-3801.
12. Baer K, Al-Hasani H, Parvaresch S, Corona T et al. Dimerization-induced activation of soluble insulin/IGF-1 receptor kinases: an alternative mechanism of activation. Biochemistry 2001; 40: 14268-14278.
13. Al-Hasani H, Passlack W, Klein HW. Phosphoryl exchange is involved in the mechanism of the insulin receptor kinase. FEBS Lett 1994; 349: 17-22.
14. Hermanto U, Zong CS, Wang LH. Inhibition of mitogen-activated protein kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen activated protein kinase activation. Cell Growth Differ 2000; 11: 655-664.
15. Tanaka A, Chance B, Quistorff B. A possible role of inorganic phosphate as a regulator of oxidative phosphorylation in combined urea synthesis and gluconeogenesis in perfused rat liver. A phosphorus magnetic resonance spectroscopy study. J Biol Chem 1989; 264: 10034-10040.
16. 2 gradient across biomembranes. FEBS Lett 2000; 475: 121-126.
17. 3) in the treatment of patients with acute promyelocytic leukaemia: the M.D. Anderson experience. Cancer 2003; 97: 2218-2224.
18. Maeda H, Hori S, Ohizumi H et al. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ 2004; 11: 737-746.